Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
503068-36-8CC1(C)OCc2cc([C@@H]3CN(CCCCCCOCCOCc4c(Cl)cccc4Cl)C(=O)O3)ccc2O1XQWNKZGGCAFXHI-SANMLTNESA-NSicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity];H370 (100%): Causes damage to organs [Danger Specific target organ toxicity, single exposure];H373 (100%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure];H411 (100%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]
P203, P260, P264, P270, P273, P280, P308+P316, P318, P319, P321, P391, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Verwenden(R)-3-[6-[2-(2,6-Dichlorobenzyloxy)ethoxy]hexyl]-5-(2,2-dimethyl-4H-benzo[1,3]dioxin-6-yl)oxazolidin-2-one is an intermediate in the preparation of Vilanterol Trifenatate (V260000), a long-acting β2 adrenergic receptor agonist.
Wird geladen…
Wird geladen…
Wird geladen…
503068-36-8